Abstract

Pancreatic cancer poses a challenge in healthcare and is one of a leading cause of cancer-related mortality. In 2021, around 1,000 new cases were diagnosed in Denmark. The disease itself is associated with a poor prognosis. Partly due to its silent nature and partly due to the lack of sensitive and specific tumour markers for early detection. The five-year survival rate among patients with pancreatic cancer in Denmark is 5-6%. I this review, we describe the current diagnostic and treatment options as well as the status on cancer-predictive biomarkers and their screening potential.

Bidragets oversatte titelNot Available
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind185
Udgave nummer23
ISSN0041-5782
StatusUdgivet - 5 jun. 2023

Emneord

  • Humans
  • Early Detection of Cancer
  • Pancreatic Neoplasms/diagnosis
  • Biomarkers, Tumor
  • Prognosis

Fingeraftryk

Dyk ned i forskningsemnerne om 'Pancreascancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater